AzTrials
AzTrials

Nerve Excitation SensitivityPERNEACNCT07160413

Peripheral Nerve Activation Sensitivity

A study testing Electric and electromagnetic stimulation in people with Nerve Excitation Sensitivity, run by Thomas Niederhauser at 1 site in Switzerland.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Volunteers will undergo various peripheral nerve stimulations (electric, electromagnetic, and temporal interference) to evaluate each method's sensitivity. The main objective is to examine the relationship between nerve activation and coil placement relative to the nerve, as well as how different coil types influence… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Nerve Excitation Sensitivity
What is being tested?
Electric and electromagnetic stimulation
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteSwitzerland
Study dates
1 Sep 2025to 31 Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Person aged > 18 years
  • Signed informed consent
  • Healthy
  • Willingness and ability to adhere to study procedures

Who cannot join

  • Known hypersensitivity to electric or electromagnetic stimulation
  • Any implanted metal or electronic device in the upper body (except dental work such as fillings or braces), e.g., active medical devices, metal implants
  • Neurological or neuromuscular disorders or conditions
  • History of seizures or epilepsy
  • Current treatment with drugs that lower seizure threshold (e.g., certain analgesics, methylxanthines, antipsychotics, antidepressants, antiepileptics, anesthetics)
  • Pregnancy or breastfeeding
Show all 12Show fewer
  • Surgical intervention of the arm within the last 4 weeks
  • Allergy to adhesives or ultrasound gel components (e.g., polyethylene glycols)
  • Skin lesions, infections, or strictures in the arm region
  • Tattoos on the stimulated (right) arm and hand, or in any area likely to be captured in video recordings
  • Inability to follow study procedures (e.g., due to language barrier, psychological disorders, dementia)
  • Participant deprived of liberty by administrative or judicial decision or under legal guardianship

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Thomas Niederhauser, PhD contact

+41 32 321 67 63

thomas.niederhauser@bfh.ch

Switzerland1 site, 1 recruiting
  • Institute for Human Centered Engineering HuCE

    Biel, Biel, 2502

    Thomas Niederhauser, Prof. Dr., +41 32 321 67 63, thomas.niederhauser@bfh.ch

    Recruiting

Other trials in Switzerland

About this study

Official title: Peripheral Nerve Activation Sensitivity to Electromagnetic and Electrical Stimulation in the Upper Arm

Volunteers will undergo various peripheral nerve stimulations (electric, electromagnetic, and temporal interference) to evaluate each method's sensitivity. The main objective is to examine the relationship between nerve activation and coil placement relative to the nerve, as well as how different coil types influence maximal nerve activation.

Being tested
Electric and electromagnetic stimulation
Keywords
Peripheral nerve stimulation, Magnetic and electric stimulation, Sensitivity of nerves to magnetic fields

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Electric and electromagnetic stimulationDevice

    Application of electromagnetic and electric stimulation using coils of different designs and electrodes to assess peripheral nerve sensitivity. The stimulation is momentary, non-therapeutic, and performed for basic science research purposes

Study groups in NCT07160413
Study groupRoleWhat they receive
StimulatedExperimentalNot described
Receives: Device: Electric and electromagnetic stimulation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Maximum nerve activation response to electromagnetic stimulation with different coils

    Maximum of the measured signals (muscle contraction from electromyography (EMG) and finger movement from accelerometer) obtained across all stimulation positions at a given stimulation intensity for each coil type. This reflects the relative sensitivity of peripheral nerves to electromagnetic stimulation with different coil designs.

    Measured: Day 1

Secondary outcomes (3)
  1. Spatial range of nerve activation with electromagnetic coils

    Distance around the stimulation position yielding the maximum response (E1), within which the measured signals (muscle contraction and finger movement) remain at least 50% of the maximum, across all coil positions at a given stimulation intensity.

    Measured: Day 1

  2. Spatial range of nerve activation with neuromuscular electrical stimulation electrodes (NMES)

    Distance around the stimulation position yielding the maximum response, within which the measured signals (muscle contraction and finger movement) remain at least 50% of the maximum, across all NMES electrode positions at a given stimulation intensity.

    Measured: Day 1

  3. Amplitude ratios of temporal interference stimulation (TIS) electrodes associated with nerve activation

    Electrode amplitude ratios during Temporal Interference Stimulation (TIS) for which measured signals remain at least 50% of the maximum signals observed at the optimal position.

    Measured: Day 1

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Sep 2025
  2. Study start1 Sep 2025 (estimated)
  3. Primary completion31 Dec 2025 (estimated)
  4. Study completion31 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07160413
Sponsor's protocol ID
2025-00776
Other IDs
108.018 IP-LS, 2025
Acronym
PERNEAC
Status last verified
Sep 2025
First submitted
29 Aug 2025
Last updated
12 Sep 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Electric and electromagnetic stimulation in people with Nerve Excitation Sensitivity, run by Thomas Niederhauser at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 12 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Thomas Niederhauser, PhD (+41 32 321 67 63, thomas.niederhauser@bfh.ch), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Maximum nerve activation response to electromagnetic stimulation with different coils (time frame: Day 1). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Sep 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in